Lab Med Online.  2011 Oct;1(4):173-178. 10.3343/lmo.2011.1.4.1.

Translation: Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

• Sacks DB
• Arnold M
• Bakris GL
• Bruns DE
• Horvath AR
• Kirkman MS
• Lernmark A
• Metzger BE
• Nathan DM

• KMID: 1993633
• DOI: http://doi.org/10.3343/lmo.2011.1.4.1

Abstract

BACKGROUND
Multiple laboratory tests are used in the diagnosis and management of patients with diabetes mellitus. The quality of the scientific evidence supporting the use of these assays varies substantially. APPROACH: An expert committee compiled evidencebased recommendations for the use of laboratory analysis in patients with diabetes. A new system was developed to grade the overall quality of the evidence and the strength of the recommendations. A draft of the guidelines was posted on the Internet, and the document was modified in response to comments. The guidelines were reviewed by the joint Evidence-Based Laboratory Medicine Committee of the AACC and the National Academy of Clinical Biochemistry and were accepted after revisions by the Professional Practice Committee and subsequent approval by the Executive Committee of the American Diabetes Association. CONTENT: In addition to the long-standing criteria based on measurement of venous plasma glucose, diabetes can be diagnosed by demonstrating increased hemoglobin A1c (HbA1c) concentrations in the blood. Monitoring of glycemic control is performed by the patients measuring their own plasma or blood glucose with meters and by laboratory analysis of Hb A1c. The potential roles of noninvasive glucose monitoring, genetic testing, and measurement of autoantibodies, urine albumin, insulin, proinsulin, C-peptide, and other analytes are addressed. SUMMARY: The guidelines provide specific recommendations based on published data or derived from expert consensus. Several analytes are found to have minimal clinical value at the present time, and measurement of them is not recommended.

MeSH Terms

Autoantibodies
Biochemistry
Blood Glucose
C-Peptide
Consensus
Diabetes Mellitus
Genetic Testing
Glucose
Hemoglobin A, Glycosylated
Hemoglobins
Humans
Insulin
Internet
Joints
Plasma
Professional Practice
Proinsulin
Autoantibodies
Blood Glucose
C-Peptide
Glucose
Hemoglobin A, Glycosylated
Hemoglobins
Insulin
Proinsulin

Reference

1. International Diabetes Federation. Diabetes atlas. 2008. 3rd ed. Brussels (Belgium): International Diabetes Federation.

2. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, et al. Full accounting of diabetes and pre-diabetes in the US population in 1988-1994 and 2005-2006. Diabetes Care. 2009. 32:287–294.

3. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, Hu FB. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009. 301:2129–2140.

4. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010. 362:1090–1101.

5. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008. 31:596–615.

6. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993. 328:1676–1685.

7. Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S, et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care. 2005. 28:2130–2135.

8. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2002. 48:436–472.